Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03501238 · ClinicalTrials.gov registry record · NA
Interaction of Salivary Proteins and Polyphenols
A NA study of Diet Habit and Diet Modification, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT03501238: Completed NA study of Diet Habit and Diet Modification, sponsored by Purdue University.
NCT03501238 is a NA study of Diet Habit and Diet Modification that has completed, run by Purdue University. The registered enrollment target is 63 participants, below the 11,773-participant average among 22 other Diet Habit trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03501238, a NA study of Diet Habit and Diet Modification, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will be chosen through an initial sensory test to find high and low-perceivers of astringency. Selected participants will drink a chocolate milk or milk substitute beverage for one week each with washout weeks in between. At the end of each week participants will taste and rate multiple beverages for their astringency and other sensory properties. Participants will provide saliva samples weekly for proteomic analysis and (potentially) analysis of polyphenols. Participants will also be asked to provide a 24 hour dietary recall once per week. Data will be analyzed to determine if there is a relationship between polyphenol exposure, astringency ratings, and salivary protein composition.
Primary Outcome
Measure relative amounts of salivary proteins in participant saliva.
Conditions Studied
Interventions
- OTHER Chocolate Milk
- OTHER Chocolate milk substitute
- OTHER Chocolate milk substitute with gelatin
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2018-01-01 |
| Phase | NA |
What the finished NCT03501238 record still lists
NCT03501238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 11,773-participant average among 22 other Diet Habit trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Diet Habit appearing as the primary indexed condition, and to 3 interventions - of which Chocolate Milk is the first listed.
NCT03501238 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03501238 about?
NCT03501238 is a clinical study titled "Interaction of Salivary Proteins and Polyphenols". Participants will be chosen through an initial sensory test to find high and low-perceivers of astringency. Selected participants will drink a chocolate milk or milk substitute beverage for one week each with washout weeks in between. At the end of each week participants will taste and rate multiple...
What is the current status of trial NCT03501238?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2017-06-08. Estimated completion is 2018-01-01.
What conditions does trial NCT03501238 study?
This clinical trial studies the following conditions: Diet Habit, Diet Modification, Taste, Altered, Saliva Altered.
What interventions are being tested in trial NCT03501238?
The interventions under investigation include: Chocolate Milk (OTHER), Chocolate milk substitute (OTHER), Chocolate milk substitute with gelatin (OTHER).
Who is sponsoring clinical trial NCT03501238?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03501238 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet Habit
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03501238's enrollment target sits among peer trials
63 14th of 22 higher than 8 of 22 other Diet Habit trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diet Habit trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
-
Project humAn dieTary daTa rEtuRN
RECRUITING · NA
-
Building Access to Food Through Systems and Solidarity
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Walnuts and Colon Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI